Interleukins 17 and 23 influence the host response to Histoplasma capsulatum

Journal of Infectious Diseases

Volumn 200, Issue 1, 2009, Pages 142-151

  Deepe Jr , George S ^a,b   Gibbons, Reta S ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD3+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FUNGUS IMMUNITY; HISTOPLASMA CAPSULATUM; HISTOPLASMOSIS; IMMUNE RESPONSE; INFLAMMATION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SURVIVAL RATE;

ANIMALS; CYTOKINES; HISTOPLASMA; HISTOPLASMOSIS; INTERLEUKIN-17; INTERLEUKIN-23; INTERLEUKINS; LUNG DISEASES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RATS;

EID: 67650682771     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/599333     Document Type: Article

References (49)

1. Deepe GS Jr, Gibbons RS, Smulian AG. Histoplasma capsulatum manifests preferential invasion of phagocytic subpopulations in murine lungs. J Leukoc Biol 2008; 84:669-78.
2. Deepe GS Jr. Histoplasma capsulatum. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practices of infectious diseases. 6th ed. Vol 2. Philadelphia: Elsevier Churchill Livingstone, 2004:3012-26.
3. Allendoerfer R, Deepe GS Jr. Blockade of endogenous TNF-a exacerbates primary and secondary pulmonary histoplasmosis by differential mechanisms. J Immunol 1998; 160:6072-82.
4. Deepe GS Jr, Gibbons R, Woodward E. Neutralization of endogenous granulocyte-macrophage colony-stimulating factor subverts the protective immune response to Histoplasma capsulatum. J Immunol 1999; 163:4985-93.
5. Deepe GS Jr, McGuinness M. Interleukin-1 and host control of pulmonary histoplasmosis. J Infect Dis 2006; 194:855-64.
6. Wu-Hsieh BA, Howard DH. Inhibition of the intracellular growth of Histoplasma capsulatum by recombinant murine gamma interferon. Infect Immun 1987;55:1014-6.
7. Wu-Hsieh BA, Lee GS, Franco M, Hofman FM. Early activation of splenic macrophages by tumor necrosis factor alpha is important in determining the outcome of experimental histoplasmosis in mice. Infect Immun 1992; 60:4230-8.
8. γ. J Immunol 1998; 160:1359-68.
9. γ. J Immunol 1995; 155:785-95.
10. Smith JG, Magee DM, Williams DM, Graybill JR. Tumor necrosis factor-α plays a role in host defense against Histoplasma capsulatum. J Infect Dis 1990; 162:1349-53.
11. Matsuzaki G, Umemura M. Interleukin-17 as an effector molecule of innate and acquired immunity against infections. Microbiol Immunol 2007;51:1139- 47.
12. Ouyang W, Kolls JK, Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 2008; 28:454-67.
13. Romani L, Zelante T, De Luca A, Fallarino F, Puccetti P. IL-17 and therapeutic kynurenines in pathogenic inflammation to fungi. J Immunol 2008; 180:5157-62.
14. Heninger E, Hogan LH, Karman J, et al. Characterization of the Histoplasma capsulatum-induced granuloma. J Immunol 2006; 177:3303-13.
15. Cain JA, Deepe GS Jr. Evolution of the primary immune response to Histoplasma capsulatum in murine lung. Infect Immun 1998; 66: 1473-81.
16. Allendoerfer R, Deepe GS Jr. Intrapulmonary response to Histoplasma capsulatum in gamma interferon knockout mice. Infect Immun 1997;65:2564-9.
17. McGeachy MJ, Bak-Jensen KS, Chen Y, et al. TGF-β and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain Th-17 cellmediated pathology. Nat Immunol 2007;8:1390-7.
18. Kom T, Bettelli E, Gao W, et al. IL-21 initiates an alternative pathway to induce proinflammatory Th 17 cells. Nature 2007;448:484-7.
19. Zelante T, De Luca A, Bonifazi P, et al. IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur J Immunol 2007;37:2695-706.
20. Allendoerfer R, Biovin GP, Deepe GS Jr. Modulation of immune responses in murine pulmonary histoplasmosis. J Infect Dis 1997; 175: 905-14.
21. Liang SC, Long AJ, Bennett F, et al. An IL-17F/A heterodimer protein is produced by mouse Thl7 cells and induces airway neutrophil recruitment. J Immunol 2007; 179:7791-9.
22. Kelly MN, Kolls JK, Happel K, et al. Interleukin-17/interleukin-17 receptor-mediated signaling is important for generation of an optimal polymorphonuclear response against Toxoplasma gondii infection. Infect Immun 2005;73:617-21.
23. Hamada S, Umemura M, Shiono T, et al. IL-17A produced by yδ T cells plays a critical role in innate immunity against Listeria monocytogenes infection in the liver. J Immunol 2008; 181:3456-63.
24. Lu YJ, Gross J, Bogaert D, et al. Interleukin-17A mediates acquired immunity to pneumococcal colonization. PLoS Pathog 2008; 4: el000159.
25. Umemura M, Yahagi A, Hamada S, et al. IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis bacille Calmette-Guerin infection. J Immunol 2007; 178:3786-96.
26. Ye P, Rodriguez FH, Kanály S, et al. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colonystimulating factor expression, neutrophil recruitment, and host defense. J Exp Med 2001; 194:519-27.
27. Rudner XL, Happel KI, Young EA, Shellito JE. Interleukin-23 (IL-23)IL-17 cytokine axis in murine Pneumocystis carinii infection. Infect Immun 2007;75:3055-61.
28. Bozza S, Zelante T, Moretti S, et al. Lack of Toll IL-1R8 exacerbates Th17 cell responses in fungal infection. J Immunol 2008; 180:4022-31.
29. Allendorfer R, Brunner GD, Deepe GS Jr. Complex requirements for nascent and memory immunity in pulmonary histoplasmosis. J Immunol 1999; 162:7389-96.
30. + T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol 2007; 8: 369-77.
31. Higgins SC, Jarnicki AG, Lavelle EC, Mills KH. TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL17-producing T cells. J Immunol 2006; 177:7980-9.
32. Miossec P. Interleukin-17 in fashion, at last: ten years after its description, its cellular source has been identified. Arthritis Rheum 2007; 56: 2111-5.
33. Weaver CT, Hatton RD, Mangan PR, Harrington LE. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 2007;25:821-52.
34. Yen D, Cheung J, Scheerens H, et al. IL-23 is essential for T cellmediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest 2006; 116:1310-6.
35. McGeachy MJ, Cua DJ. The link between IL-23 and Th 17 cell-mediated immune pathologies. Semin Immunol 2007; 19:372-6.
36. Lubberts E, Koenders MI, Oppers-Walgreen B, et al. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum 2004; 50:650-9.
37. Aggarwal S, Ghilardi N, Xie MH, de Sauvage FJ, Gurney AL. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem 2003;278:1910-4.
38. Da Silva CA, Hartl D, Liu W, Lee CG, Elias JA. TLR-2 and IL-17A in chitin-induced macrophage activation and acute inflammation. J Immunol 2008; 181:4279-86.
39. Song Q Luo L, Lei Z, et al. IL-17-producing alveolar macrophages mediate allergic lung inflammation related to asthma. J Immunol 2008;181:6117-24.
40. + Th17 mediate costimulation blockade-resistant allograft rejection in T-betdeficient mice. J Immunol 2008; 181:3906-14.
41. Tzartos JS, Friese MA, Craner MJ, et al. Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am J Pathol 2008; 172:146-55.
42. - IL-17-producing T cells are important in effector functions for the elicitation of contact hypersensitivity responses. J Immunol 2006; 177:6852-8.
43. Zhou L, Lopes JE, Chong MM, et al. TGF-β-induced Foxp3 inhibits Thl7 cell differentiation by antagonizing RORγt function. Nature 2008;453:236-40.
44. Deepe GS Jr, Gibbons RS. Protective and memory immunity to Histoplasma capsulatum in the absence of IL-10. J Immunol 2003; 171: 5353-62.
45. Zelante T, De Luca A, D'Angelo C, Moretti S, Romani L. IL-17/Thl7 in anti-fungal immunity: what's new? Eur J Immunol 2009; 39:645-8.
46. Huang W, Na L, Fidel PL, Schwarzenberger P. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis 2004; 190:624-31.
47. Gu Y, Yang J, Ouyang X, et al. Interleukin 10 suppresses Th17 cytokines secreted by macrophages and T cells. Eur J Immunol 2008; 38:1807-13.
48. McAllister F, Henry A, Kreindler JL, et al. Role of IL-17A, IL-17F, and the IL-17 receptor in regulating growth-related oncogene-alpha and granulocyte colony-stimulating factor in bronchial epithelium: implications for airway inflammation in cystic fibrosis. J Immunol 2005; 175:404-12.
49. Bettelli E, Kuchroo VK. IL-12- and IL-23-induced T helper cell subsets: birds of the same feather flock together. J Exp Med 2005;201:169-71.